← FDA Drug Approvals (Drugs@FDA)
PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVEL LABS INC · Approved 2014-08-20
Drug application
- FDA Application #
ANDA202217- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL
- Generic name
- POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL DELAYED-RELEASE TABLET
- Active ingredients
- BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
- Dosage form
- FOR SOLUTION, TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- NOVEL LABS INC
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- First approval
- 2014-08-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown